Abstract
The aim of this study was to determine the status and the role of oxidative stress and antioxidant defenses in patients with Buerger disease and atherosclerotic peripheral arterial occlusive disease (PAOD). Seventy-three subjects resembling each other in general characteristics were involved in the study: 21 with lower extremity PAOD (mean age 53.05 +/- 10.8 years, 17 men and four women), 22 with Buerger disease (mean age 38.59 +/- 6.4 years, 19 men and three women), and 30 healthy volunteers (mean age 38.59 +/- 6.4 years, 22 men and eight women). We measured the levels of plasma malondialdehyde (MDA), paraoxonase (PON1), protein carbonyls, arylesterase, nitric oxide (NO), serum oxidized low-density lipoprotein (ox-LDL) and MDA, glutathione (GSH), glutathione reductase (GSH-red), glutathione peroxidase (GSH-px), superoxide dismutase (SOD), and catalase (CAT) in erythrocytes. Plasma protein carbonyls, serum ox-LDL, and plasma and erythrocyte MDA were significantly high in the Buerger disease group compared to the PAOD and control groups (p < 0.001). Plasma PON1 levels and GSH and GSH-px levels in erythrocytes in the Buerger disease group were significantly low compared to the PAOD and control groups (p < 0.001). GSH-red, SOD, an...Continue Reading
References
Jan 1, 1978·Biochemical Pharmacology·Y Masuda, T Murano
Dec 1, 1979·Analytical Biochemistry·G L Peterson
Jan 1, 1978·Methods in Enzymology·J A Buege, S D Aust
Jul 29, 1991·FEBS Letters·M I MacknessP N Durrington
Feb 1, 1991·Atherosclerosis·M I MacknessP N Durrington
Oct 1, 1991·Clinical Genetics·N SahaS S Ratnam
Mar 1, 1991·Pharmacology & Toxicology·N K Cortas, N W Wakid
Oct 1, 1989·American Journal of Obstetrics and Gynecology·C A HubelM K McLaughlin
Jan 1, 1971·British Journal of Haematology·J Stocks, T L Dormandy
Sep 17, 1994·Lancet·J L Witztum
Apr 1, 1994·Clinica Chimica Acta; International Journal of Clinical Chemistry·Y Sun, L W Oberley
Dec 1, 1993·Atherosclerosis·M I MacknessP N Durrington
Jul 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·M NavabA M Fogelman
Dec 1, 1995·The Journal of Clinical Investigation·A D WatsonM Navab
Sep 1, 1996·Placenta·A K PoranenM Ahotupa
Nov 1, 1996·European Journal of Clinical Investigation·I WybrańskaA Dembinńska-Kieć
May 23, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·O Traub, B C Berk
Nov 18, 1998·Current Opinion in Nephrology and Hypertension·C Kitiyakara, C S Wilcox
Aug 27, 1999·Molecular Medicine Today·M Aviram
Oct 12, 1999·Nephron·G ParaghG Kakuk
Aug 14, 2001·Atherosclerosis·M Aviram, L Dornfeld
Apr 16, 2002·European Journal of Clinical Investigation·B MacknessM I Mackness
Jul 18, 2002·Atherosclerosis·Bianca FuhrmanMichael Aviram
Apr 5, 2003·Drug News & Perspectives·Bradford C. BerkRyan Hoefen
Mar 12, 2004·Metabolism: Clinical and Experimental·Sachie TsuzuraKozo Hashimoto
Mar 24, 2004·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Seval AydinSafiye Kaya
Apr 4, 2008·Clinical and Experimental Medicine·Ufuk CakatayHafize Uzun
Jul 23, 2008·Perspectives in Vascular Surgery and Endovascular Therapy·Kimon Bekelis, Nicos Labropoulos
Citations
May 21, 2015·International Journal of Molecular Sciences·Anna Hernández-AguileraJordi Camps
Dec 9, 2014·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Aluísio LimaAlexandre Silva
Apr 10, 2013·Vascular·Bahare FazeliS A Rahim Rezaee
Mar 23, 2013·Vascular·Daryoush Hamidi AlamdariBahare Fazeli
Jan 10, 2020·Environmental Science and Pollution Research International·Guanghua MaoLiuqing Yang
Apr 11, 2020·Journal of Clinical Medicine·Hiva SharebianiFerdinando Mannello
Nov 18, 2021·Bioengineered·Bo ChenJingdong Tang